Xeris Biopharma Holdings Inc — Quarterly Financial Statistics (NASDAQ:XERS) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities 1.98 M-10.03 M182 K18.43 M20.04 M 28.63 M Cash from investing activities 10.02 M-13 K-279 K-71 K-333 K -696 K Cash from financing activities 398 K-3.14 M942 K13.85 M-266 K 11.39 M Free cash flow 1.98 M-10.03 M182 K18.43 M20.04 M 28.63 M

뉴스

Xeris Pharmaceuticals, RECORLEV 힘입어 강력한 성장세

Xeris Pharmaceuticals at Barclays: Strong Growth Fueled by RECORLEV

Xeris Biopharma Holdings, Inc. (XERS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Xeris Biopharma (XERS) Reports Q4 Earnings: What Key Metrics Have to Say

Xeris Biopharma (XERS) Q4 Earnings and Revenues Surpass Estimates

제리스 바이오파마, 4분기 EPS 예상치 상회 후 주가 3% 상승

Xeris Biopharma stock up nearly 3% after Q4 EPS beat, above estimate guidance

Xeris Pharmaceuticals Q1 실적, 수익 예상치를 넘어

Xeris Pharmaceuticals earnings beat by $0.04, revenue topped estimates

제리스, 성장 가속화 속 실적 시험대 올라

Xeris Pharmaceuticals faces earnings test as growth accelerates

Why Are Shares Of Xeris Biopharma Falling Friday? - Xeris Biopharma Holdings (NASDAQ:XERS)